Search results
Results from the WOW.Com Content Network
The London-listed drugmaker said it now expects a rise of 8% to 10% in annual adjusted earnings per share, up from the 6%-9% growth previously forecast. It also expects its 2024 sales to rise in ...
GSK on Wednesday raised its full-year profit and sales forecasts for a second time, after better-than-expected quarterly sales of its newly-launched respiratory syncytial virus (RSV) vaccine. GSK ...
GSK, a multinational pharma company, scans as a bargain. For premium support please call: 800-290-4726 more ways to reach us
Is GlaxoSmithKline (GSK) a great pick from the value investor's perspective right now? Read on to know more. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
For premium support please call: 800-290-4726 more ways to reach us
Citi analysts forecast 19% earnings growth for the healthcare sector in 2025, up from 4% this year. The analysts point to the stocks' right-sized valuations and a potential improvement in ...
Top Stock Reports for Visa, GlaxoSmithKline & Anthem. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Mail. Sign in ...